Granted Patent
B2
US 12,383,759 · App. 16/919,975 · Granted Aug 12, 2025
Methods and systems for neural stimulation via visual, auditory and peripheral nerve stimulations
Assignee:
COGNITO THERAPEUTICS, INC.
A61N5/0622A61B5/0036A61B5/16A61B5/377A61B5/378A61B5/38A61B5/4088A61B5/4836A61M21/00A61N1/0456A61N1/36025A61N1/36036A61N1/36082A61N1/36092A61N1/36132A61N5/0618G02C11/10H05B47/105A61B3/113A61B5/024A61B5/05A61B5/163A61B5/168A61B5/375A61B5/398A61B5/4848A61B5/6803A61M2021/0027A61M2021/0044A61M2021/0072A61M2205/3375A61N1/0551A61N2005/0626A61N2005/0627A61N2005/0629A61N2005/0648A61N2005/0652A61N2005/0659A61N2005/0661A61N2005/0662A61N2005/0663A61N2005/0667G02C2200/10
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Systems and methods of the present disclosure are directed to systems and methods for treating cognitive dysfunction in a subject in need thereof. The system can include a light source and a speaker. A visual neural stimulation system provides, via the light source, visual stimulation having a first value of a first parameter. An auditory neural stimulation system provides, via the speaker, audio stimulation having a second value of the second parameter. A stimuli orchestration component selects, for a first time interval, one of the visual stimulation or the audio stimulation to vary based on a policy, selects, for the first time interval, the other of the visual stimulation or the audio stimulation to keep constant based on the policy, and provides causes the one of the visual neural stimulation system or the auditory neural stimulation system to vary the one of the visual stimulation or the audio stimulation.
Claims (17)
1. A system for treating a symptom of Alzheimer's disease or dementia in a subject in need thereof, the system comprising:
(a) a stimulus-emitting component capable of providing a non-invasive auditory stimulus or a non-invasive visual stimulus to said subject, wherein said stimulus-emitting component is configured to emit a wave having a frequency band from about 30 to about 60 Hertz (Hz);
(b) one or more processors, individually or collectively programmed to execute a set of instructions comprising:
(i) instructing said stimulus-emitting component to emit said non-invasive auditory stimulus or said non-invasive visual stimulus to said subject in need thereof;
(ii) receiving an indication of a physiological, cognitive, neural, or physical assessment of said subject from a feedback sensor configured to receive said indication of said physiological, cognitive, neural, or physical assessment of said subject; and
(iii) instructing said stimulus-emitting component, based on said indication, to adjust a parameter associated with said non-invasive auditory stimulus or said non-invasive visual stimulus, thereby inducing gamma oscillations in at least one brain region of said subject to treat said symptom of Alzheimer's disease or dementia in said subject in need thereof;
(c) a memory device configured to store said set of instructions; and
(d) said feedback sensor.
2. The system of claim 1 , wherein said physical assessment of said subject involves ascertaining:
(i) said subject's compliance with a proper use of said system;
(ii) said subject's compliance with a proper positioning of said system;
(iii) eye status, alert or sleep status of said subject; or
(d) environment or surroundings of said subject.
3. The system of claim 1 , wherein said neural assessment of said subject is received using a brain wave sensor, an electroencephalography (EEG) device, an electrooculography (EOG) devices, or a magnetoencephalography (MEG) device.
4. The system of claim 1 , wherein said cognitive assessment of said subject is obtained through questions posed to said subject, activities and tasks performed by said subject in response to a prompt, or behaviors exhibited by said subject.
5. The system of claim 1 , wherein said set of instructions further comprise instructing said stimulus-emitting component to lengthen or shorten a duration of said stimulus in response to said indication of said physiological, cognitive, neural, or physical assessment.
6. The system of claim 1 , wherein said physical assessment of said subject is performed to determine a hearing ability of the subject.
Assignments (2)
SECURITY INTEREST
Recorded Jan 23, 2026
From: COGNITO THERAPEUTICS, INC.
To: HERCULES CAPITAL, INC.
Reel/Frame 073568/0710 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 2, 2020
From: MALCHANO, ZACHARY JOHN HAMBRECHT; WILLIAMS, MARTIN WARREN
To: COGNITO THERAPEUTICS, INC.
Reel/Frame 053112/0530 →
Continuity (14)
Provisional Application
62431725
· Dec 8, 2016
Provisional Application
62431720
· Dec 8, 2016
Provisional Application
62431698
· Dec 8, 2016
Provisional Application
62431702
· Dec 8, 2016
Provisional Application
62423536
· Nov 17, 2016
Provisional Application
62423452
· Nov 17, 2016
Provisional Application
62423569
· Nov 17, 2016
Provisional Application
62423598
· Nov 17, 2016
Provisional Application
62423532
· Nov 17, 2016
Provisional Application
62423557
· Nov 17, 2016
Provisional Application
62423517
· Nov 17, 2016
References Cited (400)
US 4315502A
· Gorges
· 1982
[cited by applicant]
US 4449047A
· Monroe
· 1984
[cited by applicant]
US 4456910A
· DiMassimo et al.
· 1984
[cited by applicant]
US 4674852A
· Tanaka
· 1987
[cited by applicant]
US 5151687A
· Younger
· 1992
[cited by applicant]
US 5534953A
· Schmielau
· 1996
[cited by applicant]
US 5659287A
· Donati et al.
· 1997
[cited by applicant]
US 5923398A
· Goldman
· 1999
[cited by applicant]
US 5934967A
· Brown et al.
· 1999
[cited by applicant]
US 6066163A
· John
· 2000
[cited by applicant]
US 6071229A
· Rubins
· 2000
[cited by applicant]
US 6113537A
· Castano
· 2000
[cited by applicant]
US 6167298A
· Levin
· 2000
[cited by applicant]
US 6206537B1
· Hauck
· 2001
[cited by applicant]
US 6234953B1
· Thomas et al.
· 2001
[cited by applicant]
US 6443977B1
· Jaillet
· 2002
[cited by applicant]
US 6463328B1
· John
· 2002
[cited by applicant]
US 6539263B1
· Schiff et al.
· 2003
[cited by applicant]
US 6733490B1
· Falsini et al.
· 2004
[cited by applicant]
US 7010356B2
· Jog et al.
· 2006
[cited by applicant]
US 7361074B1
· Periman et al.
· 2008
[cited by applicant]
US 7446785B1
· Hewlett et al.
· 2008
[cited by applicant]
US 7569545B2
· Li et al.
· 2009
[cited by applicant]
US 7645226B2
· Shealy et al.
· 2010
[cited by applicant]
US 7715910B2
· Hargrove et al.
· 2010
[cited by applicant]
US 7748846B2
· Todd
· 2010
[cited by applicant]
US 7769439B2
· Vesely et al.
· 2010
[cited by applicant]
US 8070669B2
· Brunelle et al.
· 2011
[cited by applicant]
US 8083392B2
· Chien
· 2011
[cited by applicant]
US 8121694B2
· Molnar et al.
· 2012
[cited by applicant]
US 8239030B1
· Hagedorn et al.
· 2012
[cited by applicant]
US 8267851B1
· Kroll
· 2012
[cited by applicant]
US 8280502B2
· Hargrove et al.
· 2012
[cited by applicant]
US 8328420B2
· Abreu
· 2012
[cited by applicant]
US 8380314B2
· Panken et al.
· 2013
[cited by applicant]
US 8396545B2
· Berridge et al.
· 2013
[cited by applicant]
US 8423144B2
· Tass et al.
· 2013
[cited by applicant]
US 8543219B2
· Tass
· 2013
[cited by applicant]
US 8577470B2
· Assaf et al.
· 2013
[cited by applicant]
US 8579793B1
· Honeycutt et al.
· 2013
[cited by applicant]
US 8591392B2
· Bentwich et al.
· 2013
[cited by applicant]
US 8636640B2
· Chang
· 2014
[cited by applicant]
US 8700167B2
· Sabel
· 2014
[cited by applicant]
US 8845704B2
· Dunning et al.
· 2014
[cited by applicant]
US 8892207B2
· Nelson et al.
· 2014
[cited by applicant]
US 8894696B2
· Hurst
· 2014
[cited by applicant]
US 8914119B2
· Wu et al.
· 2014
[cited by applicant]
US 8932218B1
· Thompson
· 2015
[cited by applicant]
US 8942809B2
· Assaf et al.
· 2015
[cited by applicant]
US 9119583B2
· Tass
· 2015
[cited by applicant]
US 9272118B1
· Acton
· 2016
[cited by applicant]
US 9302069B2
· Tass et al.
· 2016
[cited by applicant]
US 9629976B1
· Acton
· 2017
[cited by applicant]
US 20010027278A1
· Kaufman et al.
· 2001
[cited by applicant]
US 20010039012A1
· Lapidus
· 2001
[cited by applicant]
US 20050070977A1
· Molina
· 2005
[cited by applicant]
US 20070038142A1
· Todd et al.
· 2007
[cited by applicant]
US 20070191727A1
· Fadem
· 2007
[cited by applicant]
US 20070225773A1
· Shen et al.
· 2007
[cited by applicant]
US 20070253561A1
· Williams et al.
· 2007
[cited by applicant]
US 20080181882A1
· Hahn
· 2008
[cited by applicant]
US 20080255949A1
· Genco et al.
· 2008
[cited by applicant]
US 20090005837A1
· Olmstead
· 2009
[cited by applicant]
US 20090093403A1
· Zhang et al.
· 2009
[cited by applicant]
US 20090270776A1
· Chang
· 2009
[cited by applicant]
US 20100190129A1
· Paz
· 2010
[cited by applicant]
US 20100217358A1
· Hebert et al.
· 2010
[cited by applicant]
US 20100274329A1
· Bradley et al.
· 2010
[cited by applicant]
US 20120065709A1
· Dunning et al.
· 2012
[cited by applicant]
US 20120289869A1
· Tyler
· 2012
[cited by applicant]
US 20130211238A1
· DeCharms
· 2013
[cited by examiner]
US 20130338738A1
· Garcia Molina et al.
· 2013
[cited by applicant]
US 20140303025A1
· Van Keuren-Jensen et al.
· 2014
[cited by applicant]
US 20140303424A1
· Glass
· 2014
[cited by applicant]
US 20140316192A1
· De Zambotti et al.
· 2014
[cited by applicant]
US 20140324138A1
· Wentz et al.
· 2014
[cited by applicant]
US 20140336514A1
· Peyman
· 2014
[cited by applicant]
US 20150002025A1
· Maricic et al.
· 2015
[cited by applicant]
US 20150157604A1
· Morozova et al.
· 2015
[cited by applicant]
US 20150337030A1
· Abeliovich
· 2015
[cited by applicant]
US 20160067087A1
· Tedford et al.
· 2016
[cited by applicant]
US 20160091758A1
· Yoneyama
· 2016
[cited by applicant]
US 20160235980A1
· Berman et al.
· 2016
[cited by applicant]
US 20170143966A1
· Reymers et al.
· 2017
[cited by applicant]
US 20190030190A1
· Peyman
· 2019
[cited by applicant]
US 20190126056A1
· Vlådila Bogdan
· 2019
[cited by applicant]
US 20190388020A1
· Stauch et al.
· 2019
[cited by applicant]
US 20210030998A1
· Wong
· 2021
[cited by applicant]
US 20210339043A1
· Malchano et al.
· 2021
[cited by applicant]
US 20220008746A1
· Malchano et al.
· 2022
[cited by applicant]
US 20230173295A1
· Kim et al.
· 2023
[cited by applicant]
US 20230181905A1
· Tsai et al.
· 2023
[cited by applicant]
US 20240293680A1
· Malchano et al.
· 2024
[cited by applicant]
US 20240325780A1
· Malchano et al.
· 2024
[cited by applicant]
US 20250001203A1
· Malchano et al.
· 2025
[cited by applicant]
CA 2979687A1
· 2016
[cited by applicant]
CN 102791332A
· 2012
[cited by applicant]
CN 103298480A
· 2013
[cited by applicant]
CN 103492564A
· 2014
[cited by applicant]
CN 104039353A
· 2014
[cited by applicant]
CN 104783788A
· 2015
[cited by applicant]
CN 103932701B
· 2015
[cited by applicant]
CN 105278387A
· 2016
[cited by applicant]
CN 106103711A
· 2016
[cited by applicant]
CN 107002076A
· 2017
[cited by applicant]
EP 0911398A3
· 2003
[cited by applicant]
EP 1642609A1
· 2006
[cited by applicant]
EP 2075035A1
· 2009
[cited by applicant]
EP 2489402A2
· 2012
[cited by applicant]
EP 3694593A1
· 2020
[cited by applicant]
EP 3541467B1
· 2024
[cited by applicant]
IT RM20090027A1
· 2010
[cited by applicant]
JP H08150210A
· 1996
[cited by applicant]
JP 2006525039A
· 2006
[cited by applicant]
JP 2008520280A
· 2008
[cited by applicant]
JP 2011514194A
· 2011
[cited by applicant]
JP 2014071825A
· 2014
[cited by applicant]
JP 2015519096A
· 2015
[cited by applicant]
JP 2018525754A
· 2018
[cited by applicant]
KR 20020025884A
· 2002
[cited by applicant]
KR 20130101596A
· 2013
[cited by applicant]
KR 20140144272A
· 2014
[cited by applicant]
KR 20160017099A
· 2016
[cited by applicant]
KR 20160129752
· 2016
[cited by applicant]
KR 1020160129752A
· 2016
[cited by applicant]
WO WO9716196A1
· 1997
[cited by applicant]
WO WO0184141A1
· 2001
[cited by applicant]
WO WO2006055582A2
· 2006
[cited by applicant]
WO WO2007062367A2
· 2007
[cited by applicant]
WO WO2008041129A2
· 2008
[cited by applicant]
WO WO2008101128A1
· 2008
[cited by applicant]
WO WO2008147958A1
· 2008
[cited by applicant]
WO WO2010123577A2
· 2010
[cited by applicant]
WO WO2011042908A1
· 2011
[cited by applicant]
WO WO2011057028A1
· 2011
[cited by applicant]
WO WO2012024243A1
· 2012
[cited by applicant]
WO WO2013061597A1
· 2013
[cited by applicant]
WO WO2013152348A1
· 2013
[cited by applicant]
WO WO2014040175A1
· 2014
[cited by applicant]
WO WO2014107795A1
· 2014
[cited by applicant]
WO WO2014130960A1
· 2014
[cited by applicant]
WO WO2014162271A2
· 2014
[cited by applicant]
WO WO2014179331A2
· 2014
[cited by applicant]
WO WO2015034673A1
· 2015
[cited by applicant]
WO WO2015066679A2
· 2015
[cited by applicant]
WO WO2015149170A1
· 2015
[cited by applicant]
WO WO2017091698A1
· 2017
[cited by applicant]
WO WO2017091758A1
· 2017
[cited by applicant]
WO WO2017172728A1
· 2017
[cited by applicant]
WO WO2018094226A1
· 2018
[cited by applicant]
WO WO2019046338A1
· 2019
[cited by applicant]
WO WO2019241430A2
· 2019
[cited by applicant]
WO WO2021221879A1
· 2021
[cited by applicant]
WO WO2022192277A1
· 2022
[cited by applicant]
Final Office Action for U.S. Appl. No. 16/404,302, dated Jan. 28, 2020.
[cited by applicant]
Final Office Action for U.S. Appl. No. 16/415,825, dated Jan. 27, 2020.
[cited by applicant]
Final Office Action for U.S. Appl. No. 16/427,276, dated Nov. 22, 2019.
[cited by applicant]
Final Office Action on U.S. Appl. No. 15/816,238, dated Nov. 30, 2018.
[cited by applicant]
International Preliminary Report on Patentability for PCT Appl. No. PCT/US2017/062328, mailed on May 31, 2019.
[cited by applicant]
International Preliminary Report on Patentability for PCT Appl. No. PCT/US2017/062333, mailed May 31, 2019.
[cited by applicant]
International Search Report and Written Opinion for International Appl. No. PCT/US2017/062328, mailed on May 3, 2018.
[cited by applicant]
International Search Report and Written Opinion for International Appl. No. PCT/US2017/062335, mailed on Apr. 12, 2018.
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2017/062333, mailed on Jun. 20, 2018.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/816,238, dated Feb. 28, 2018.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/404,302, dated Sep. 6, 2019.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/415,825, dated Jun. 13, 2019.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/427,276, dated Jul. 31, 2019.
[cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/427,276, dated Feb. 24, 2020.
[cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/427,276, dated May 6, 2020.
[cited by applicant]
Notice of Allowance for U.S. Appl. No. 15/816,222, dated Jan. 24, 2019.
[cited by applicant]
Notice of Allowance for U.S. Appl. No. 15/816,222, dated Mar. 4, 2019.
[cited by applicant]
Notice of Allowance on U.S. Appl. No. 15/816,233, dated Jan. 10, 2019.
[cited by applicant]
Notice of Allowance on U.S. Appl. No. 15/816,238, dated Mar. 19, 2019.
[cited by applicant]
US Non-Final Office Action for U.S. Appl. No. 15/816,222, dated Jun. 15, 2018.
[cited by applicant]
US Non-Final Office Action for U.S. Appl. No. 15/816,233, dated Sep. 21, 2018.
[cited by applicant]
Aronov, D. et al., “Engagement of neural circuits underlying 2D spatial navigation in a rodent virtual reality system,” Neuron, vol. 84 (Oct. 2014): 442-456.
[cited by applicant]
Barton, A. “Sound vibration treatment may boost brain activity in Alzheimer's patients,” The Globe and Mail (2016): http://www.theglobeandmail.com/life/health-and-fitness/health/sound-vibration-treatment-may-boost-brain…
[cited by applicant]
Bartos, M. et al., “Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks,” Nature Reviews Neuroscience, vol. 8 (Jan. 2007): 45-56.
[cited by applicant]
Basar, E. et al., “Delay of cognitive gamma responses in Alzheimer's disease,” Neurolmage: Clinical, vol. 11 (2016): 106-115.
[cited by applicant]
Bero, A. et al., “Neuronal activity regulates the regional vulnerability to amyloid-β deposition,” Nature Neuroscience, vol. 14 (May 2011): 750-756.
[cited by applicant]
Boissonneault, V et al., “Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease,” Brain, vol. 132 (Apr. 2009): 1078-1092.
[cited by applicant]
Bragin, A. et al., “Gamma (40-100 Hz) oscillation in the hippocampus of the behaving rat,” Journal of Neuroscience, vol. 15 (Jan. 1995): 47-60.
[cited by applicant]
“Brainsway: Deep TMS Therapy,” Brainsway (2014): http://www.brainsway.com/us.
[cited by applicant]
Briones et al., “Dysregulation in myelination mediated by persistent neuroinflammation: possible mechanisms in chemotherapy-related cognitive impairment” Brain, behavior, and immunity 35 (2014): 23-32.
[cited by applicant]
Busche, M. et al., “Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models,” Nature Neuroscience, vol. 18 (Dec. 2015): 1725-1727.
[cited by applicant]
Buzsaki et al., “Mechanisms of Gamma Oscillations,” Rev. Neurosci. 35, 203-25 (2012).
[cited by applicant]
Buzsaki, G. et al., “Scaling brain size, keeping timing: evolutionary preservation of brain rhythms,” Neuron, vol. 80 (Oct. 2013): 751-764.
[cited by applicant]
Buzsaki, G. et al., “Hippocampal network patterns of activity in the mouse,” Neuroscience, vol. 116 (2003): 201-211.
[cited by applicant]
Buzsaki, G. “Theta oscillations in the hippocampus,” Neuron, vol. 33 (Jan. 2002): 325-340.
[cited by applicant]
Buzsaki. Rhythms of the Brain. New York: Oxford University Press. (465 pgs) (2006).
[cited by applicant]
Cardin, J. et al., “Driving fast-spiking cells induces gamma rhythm and controls sensory responses,” Nature, vol. 459 (Apr. 2009): 663-667.
[cited by applicant]
Carr, M. et al., “Hippocampal replay in the awake state: a potential substrate for memory consolidation and retrieval,” Nature Neuroscience, vol. 14 (Feb. 2011): 147-153.
[cited by applicant]
Carr, M. et al., “Transient slow gamma synchrony underlies hippocampal memory replay,” Neuron, vol. 75 (Aug. 2012): 700-713.
[cited by applicant]
Cataldo et al.: Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol. 157(1):277-…
[cited by applicant]
Chitu, V. et al., “Colony-stimulating factor-1 in immunity and inflammation,” Current Opinion in Immunology, vol. 18 (Feb. 2006): 39-48.
[cited by applicant]
Chiu, et al. (2013). A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 4, 385-401.
[cited by applicant]
Chung, et al. Structural and molecular interrogation of intact biological systems. Nature. May 16, 2013;497(7449):332-7. doi: 10.1038/nature12107. Epub Apr. 10, 2013.
[cited by applicant]
Cirrito, J. et al., “In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life,” The Journal of Neuroscience, vol. 23 (Oct. 2003): 8844-…
[cited by applicant]
Clements-Cortes, A. “Sound Stimulation in Patients With Alzheimer's Disease,” Annals of Long-Term Care: Clinical Care and Aging, vol. 23 (May 2015): 10-16.
[cited by applicant]
Clements-Cortes et al., “Short-term effects of rhythmic sensory stimulation in Alzheimer's disease: An exploratory pilot study.” Journal of Alzheimer's Disease 52.2 (2016): 651-660.
[cited by applicant]
Colgin, L. et al., “Frequency of gamma oscillations routes flow of information in the hippocampus,” Nature, vol. 462 (Nov. 2009): 353-357.
[cited by applicant]
Colgin, L. et al., “Gamma oscillations in the hippocampus,” Physiology, vol. 25 (Oct. 2010): 319-329.
[cited by applicant]
Correa et al., “A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients.” Brain imaging and behavior 7.4 (2013): 478-490.
[cited by applicant]
Cronk, J. et al., “Methyl-CpG binding protein 2 regulates microglia and macrophage gene expression in response to inflammatory stimuli,” Immunity, vol. 42 (Apr. 2015): 679-691.
[cited by applicant]
Crotti et al., Mutant Huntingtin Promotes Autonomous Microglia Activation via Myeloid Lineage-Determining Factors, Nature Neuroscience, vol. 17, pp. 513-521, 2014.
[cited by applicant]
Das, U. et al., “Activity-induced convergence of App and Bace-1 in acidic microdomains via an endocytosis-dependent pathway,” Neuron, vol. 79 (Aug. 2013): 447-460.
[cited by applicant]
Eckhorn, R. et al., “Coherent Oscillations: a Mechanism of Feature Linking in the Visual Cortex,” Biological Cybernetics, vol. 60 (1988): 121-130.
[cited by applicant]
Erny et al., Host Microbiota Constantly Control Maturation and Function of Microglia in the CNS, Nature Neuroscience, vol. 18, pp. 965-977, 2015.
[cited by applicant]
Final Office Action dated Jun. 4, 2018 for U.S. Appl. No. 15/360,637, 11 pages.
[cited by applicant]
Foster, D. et al., “Reverse replay of behavioural sequences in hippocampal place cells during the awake state,” Nature, vol. 440 (Mar. 2006):680-683.
[cited by applicant]
Fries, P. et al., “The gamma cycle,” Trends in Neurosciences, vol. 30 (Jul. 2007): 309-316.
[cited by applicant]
Gibson et al., “Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain.” Science 344.6183 (2014). 27 pages.
[cited by applicant]
Gillepsie, A. et al., “Apolipoprotein E4 Causes Age-Dependent Disruption of Slow Gamma Oscillations during Hippocampal Sharp-Wave Ripples,” Neuron, vol. 90 (May 2016): 740-751.
[cited by applicant]
Gjoneska, E. et al., “Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease,” Nature, vol. 518 (Feb. 2015): 365-369.
[cited by applicant]
Good Vibrations Can Help Alzheimer's Patients, Awakening from Alzheimer's http://www.awakeningfromalzheimers.com/good-vibrations-can-help-alzheimers-patients/, Internet Archive Wayback Machine earliest Internet archived…
[cited by applicant]
Gosselin et al., Environment Drives Selection and Function of Enhancers Controlling Tissue-Specific Macrophage Identities, Cell, vol. 159, pp. 1327-1340, 2014.
[cited by applicant]
Goutagny, R. et al., “Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease,” European Journal of Neuroscience, vol. 37 (Jun. 201…
[cited by applicant]
Gray, C. et al., “Chattering cells: superficial pyramidal neurons contributing to the generation of synchronous oscillations in the visual cortex,” Science, vol. 274 (Oct. 1996): 109-113.
[cited by applicant]
Gray, C. et al., “Oscillatory responses in cat visual cortex exhibit inter-columnar synchronization which reflects global stimulus properties,” Nature, vol. 338 (Mar. 1989): 334-337.
[cited by applicant]
Harvey, C. et al., “Intracellular dynamics of hippocampal place cells during virtual navigation,” Nature, vol. 461 (Oct. 2009): 941-946.
[cited by applicant]
Helwig, M. et al., “The neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteins,” The Journal of Biological Chemistry, vol. 288 (Jan. 2013): 1114-1124.
[cited by applicant]
Heneka, M. et al., “Innate immune activation in neurodegenerative disease,” Nature Reviews Immunology, vol. 14 (Jul. 2014): 463-477.
[cited by applicant]
Hermelink, “Chemotherapy and cognitive function in breast cancer patients: the so-called chemo brain.” Journal of the National Cancer Institute Monographs 2015.51 (2015): 67-69.
[cited by applicant]
Herrmann, C. et al., “Human EEG gamma oscillations in neuropsychiatric disorders,” Clinical Neurophysiology, vol. 116 (Dec. 2005): 2719-2733. Epub Oct. 25, 2005.
[cited by applicant]
Herrmann, C. et al.: Human EEG responses to 1-100 Hz flicker: resonance phenomena in visual cortex and their potential correlation to cognitive phenomena. Experimental Brain Research 137:346-353 (2001).
[cited by applicant]
Hsiao, F. et al., “Altered Oscillation and Synchronization of Default-Mode Network Activity in Mild Alzheimer's Disease Compared to Mild Cognitive Impairment: an Electrophysiological Study,” PLOS One, vol. 8 (Jul. 2013)…
[cited by applicant]
Huang, S. et al., “Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages,” Nature Immunology, vol. 15 (Sep. 2014): 846-855.
[cited by applicant]
Iaccarino et al. “Gamma frequency entrainment attenuates amyloid load and modifies microglia.” Nature 540.7632 (2016): 230-235.
[cited by applicant]
Iliff, J. et al., “A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β,” Science Translational Medicine, vol. 4 (Aug. 2012): 147.
[cited by applicant]
International Search Report and Written Opinion in International Patent Application No. PCT/US18/55258 mailed Dec. 27, 2018. 16 pages.
[cited by applicant]
International Search Report and Written Opinion in International Patent Application No. PCT/US2018/051785, mailed on Jan. 24, 2019.
[cited by applicant]
International Search Report and Written Opinion in International Patent Application No. PCT/US2021/028776 mailed Aug. 13, 2021, 19 pages.
[cited by applicant]
International Search Report and Written Opinion issued by the International Searching Authority for International Application No. PCT/US16/63536, dated Mar. 27, 2017, 19 pages.
[cited by applicant]
International Search Report in PCT Application No. PCT/US2021/060146 mailed Feb. 11, 2022, 15 pages.
[cited by applicant]
Israel, M. et al., “Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells,” Nature, vol. 482 (Jan. 2012): 216-220.
[cited by applicant]
Jeong, J. “EEG dynamics in patients with Alzheimer's disease,” Clinical Neurophysiology, vol. 115 (Aug. 2004): 1490-1505.
[cited by applicant]
Koenig, T. et al., “Decreased EEG synchronization in Alzheimer's disease and mild cognitive impairment,” Neurobiology of Aging, vol. 26 (Feb. 2005): 165-171.
[cited by applicant]
Kreutzberg, G. “Microglia: a sensor for pathological events in the CNS,” Trends in Neurosciences, vol. 19 (Sep. 1996): 312-318.
[cited by applicant]
Krynetskiy et al., “Establishing a model for assessing DNA damage in murine brain cells as a molecular marker of chemotherapy-associated cognitive impairment.” Life sciences 93.17 (2013): 605-610.
[cited by applicant]
Kurudenkandy, F. et al., “Amyloid-β-Induced Action Potential Desynchronization and Degradation of Hippocampal Gamma Oscillations Is Prevented by Interference with Peptide Conformation Change and Aggregation,” The Journa…
[cited by applicant]
Leinenga, G. et al., “Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model,” Science Translational Medicine, vol. 7 (Mar. 2015): 278.
[cited by applicant]
Li, F. et al., “Effect of electroacupuncture stimulation of “Baihui” (GV 20) and “Yongquan” (KI 1) on expression of hippocampal amyloid-β and low density lipoprotein receptor-related protein-1 in APP/PS 1 transgenic mic…
[cited by applicant]
Lok, K. et al., “Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background,” Neuroscience Letters, vol. 557 (Dec. 2013): 84-89.
[cited by applicant]
Martorell et al., Multi-sensory Gamma Stimulation Ameliorates Alzheimer's-Associated Pathology and Improves Cognition. Cell. Mar. 14, 2019. https://doi.org/10.1016/j.cell.2019.02.014.
[cited by applicant]
Mastrangelo, M. et al., “Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice,” BMC Neuroscience, vol. 9 (Aug. 2008)…
[cited by applicant]
Meyers, “How chemotherapy damages the central nervous system.” Journal of biology 7.4 (2008): 11. 3 pages.
[cited by applicant]
Mind Alive Inc. http://mindalive.com/ Internet Archive Wayback Machine earliest Internet archived date Mar. 2, 2001, 2 pages.
[cited by applicant]
Mind Gear http://Mindlightz.com, Internet Archive Wayback Machine earliest Internet archived date Mar. 1, 2015, 5 pages.
[cited by applicant]
Mind Machines http://www.mindmachines.com/: Internet Archive Wayback Machine earliest Internet archived date Dec. 7, 1998, 6 pages.
[cited by applicant]
Mind Mods http://www.mindmods.com/, Internet Archive Wayback Machine earliest. Internet archived date Mar. 12, 2008, 2 pages.
[cited by applicant]
Mind Place http://mindplace.com/, Internet Archive Wayback Machine earliest Internet archived date Dec. 2, 1998, 4 pages.
[cited by applicant]
Mitrasinovic, O. et al., “Microglial overexpression of the M-CSF receptor augments phagocytosis of opsonized Aβ,” Neurobiology of Aging, vol. 24 (Oct. 2003): 807-815.
[cited by applicant]
Neuronix http://neuronixmedical.com, Internet Archive Wayback Machine earliest Internet archived date Nov. 16, 2009, 2 pages.
[cited by applicant]
Neuronix http://neurotronics.eu/, Internet Archive Wayback Machine earliest Internet archived date Sep. 24, 2008, 2 pages.
[cited by applicant]
Neurotronics http://neurotronics.eu/, Internet Archive Wayback Machine earliest Internet archived date Sep. 24, 2008, 2 pages.
[cited by applicant]
Oakley, H. et al., “Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation,” Journal …
[cited by applicant]
O'Connor et al., “The use of the puzzle box as a means of assessing the efficacy of environmental enrichment.” JoVE (Journal of Visualized Experiments) 94 (2014): e52225. 8 pages.
[cited by applicant]
Ohmi et al. Defects in the medial entorhinal cortex and dentate gyrus in the mouse model of Sanfilippo syndrome type B. PLoS One 6:e27461 (2011).
[cited by applicant]
Palop et al., Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease, Neuron, 55: 697-711 (2007).
[cited by applicant]
Paro Therapeutic Robot http://www.parorobots.com/: Internet Archive Wayback Machine earliest Internet Archived date Dec. 4, 2008, 2 pages.
[cited by applicant]
Pastor et al. “Activation of human cerebral and cerebellar cortex by auditory stimulation at 40 Hz.” Journal of Neuroscience 22.23 (2002): 10501-10506.
[cited by applicant]
Pericic, D. et al., “Sex differences in the response to GABA antagonists depend on the route of drug administration,” Experimental Brain Research, vol. 115 (Jun. 1997): 187-190.
[cited by applicant]
Poza et al. “Analysis of spontaneous MEG activity in patients with Alzheimer's disease using spectral entropies.” 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, …
[cited by applicant]
PSIO Manual, PSiO http://www.psioplanet.com/download/manuals/manuel-psio-1.1-EN.pdf, http://www.psoplanet.com/, Internet Archive Wayback Machine earliest Internet archived date Mar. 2, 2013, 16 pages.
[cited by applicant]
Raivich, G. et al., “Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function,” Brain Research Reviews, vol. 30 (Aug. 1999): 77-105.
[cited by applicant]
Ravassard, P. et al., “Multisensory control of hippocampal spatiotemporal selectivity,” Science, vol. 340 (Jun. 2013): 1342-1346.
[cited by applicant]
Santarecchi “Individual differences and specificity of prefrontal gamma frequency-tACS on fluid intelligence capabilities.” Cortex 75 (2016): 33-43.
[cited by applicant]
Sauer et al., “Impaired fast-spiking interneuron function in a genetic mouse model of depression,”eLIFE, vol. 4., Mar. 5, 2015, pp. 1-20.
[cited by applicant]
Seibenhener et al., “Use of the open field maze to measure locomotor and anxiety-like behavior in mice.” JoVE (Journal of Visualized Experiments) 96 (2015): e52434. 9 pages.
[cited by applicant]
Selkoe, D. et al., “The role of APP processing and trafficking pathways in the formation of amyloid beta-protein,” Annals of the New York Academy of Sciences (Jan. 1996): 57-64.
[cited by applicant]
Siegle, J. et al., “Enhancement of Encoding and retrieval functions through theta phase-specific manipulation of hippocampus,” ELife Sciences Publications (Jul. 2014).
[cited by applicant]
Smith et al., “The validity of neuropathy and neuropathic pain measures in patients with cancer receiving taxanes and platinums.” Oncology nursing forum. vol. 38. No. 2. 2011. 10 pages.
[cited by applicant]
Stam, C. et al., “Generalized synchronization of MEG recordings in Alzheimer's Disease: evidence for involvement of the gamma band,” Journal of Clinical Neurophysiology, vol. 19 (Dec. 2002): 562-574.
[cited by applicant]
Subramanian, Aravind, et al., Gene Set Enrichment Analysis: a Knowledge-based Approach for Interpreting Genome-wide Expression Profiles. Proceedings of the National Academy of Sciences of the United States of America 10…
[cited by applicant]
Sudol, K. et al., “Generating Differentially Targeted Amyloid-β Specific Intrabodies as a Passive Vaccination Strategy for Alzheimer's Disease,” Molecular Therapy, vol. 17 (Dec. 2009): 2031-2040.
[cited by applicant]
Tanaka et al.: Analysis of MEG Auditory 40-Hz Response by Event-Related Coherence. ITEIS 125.6 (2005): 898-903.
[cited by applicant]
Thakurela, S. et al., “Dynamics and function of distal regulatory elements during neurogenesis and neuroplasticity,” Genome Research, vol. 25 (Sep. 2015): 1309-1324.
[cited by applicant]
Transparent Corporation https://www.transparentcorp.com/, Internet Archive Wayback Machine earliest Internet archived date Jan. 10, 1998, 3 pages.
[cited by applicant]
Trapnell et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature protocols 7:562-578 (2012).
[cited by applicant]
Trapnell, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. May 2010;28(5):511-5. doi: 10.1038/nbt. 1621. Epub Ma…
[cited by applicant]
Traub, R. et al., “Analysis of gamma rhythms in the rat hippocampus in vitro and in vivo,” the Journal of Physiology, vol. 493 (Jun. 1996): 471-484.
[cited by applicant]
U.S. Appl. No. 17/486,165 Office Action dated Jan. 17, 2024.
[cited by applicant]
Verret et al., Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model, Cell, 149(3): 708-721 (2012).
[cited by applicant]
Walsh et al.: The open-field test: a critical review. Psychological bulletin 83.3:482-504 (1976). DOI:10.1037/0033-2909.83.3.482.
[cited by applicant]
Wang, et al.: TREM2 lipid sensing sustains the microglial response in an Alzheimer's dis-ease model. Cell 160:1061-1071 (2015).
[cited by applicant]
Wang et al., “The gamma frequency band neural oscillation: generation mechanisms and functions.” Progress in Biochemistry and Biophysics 38.8 (2011): 688-693. English Abstract.
[cited by applicant]
Wang: Neurophysiological and computational principles of cortical rhythms in cognition. Physiol Rev 90:1195-268 (2010).
[cited by applicant]
Ylinen, A. et al., “Sharp wave-associated high-frequency oscillation (200 Hz) in the intact hippocampus: network and intracellular mechanisms,” Journal of Neuroscience, vol. 15 (Jan. 1995): 30-46.
[cited by applicant]
Yoshiyama et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53(3):337-351 (2007).
[cited by applicant]
Yu, H. et al., “Tet3 regulates synaptic transmission and homeostatic plasticity via DNA oxidation and repair,” Nature Neuroscience, vol. 18 (Jun. 2015): 836-843.
[cited by applicant]
Zhang et al., An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex, Journal of Neuroscience Research, vol. 34, pp. 11929-11947, 2014.
[cited by applicant]
Final Office Action dated Dec. 7, 2023 issued in U.S. Appl. No. 17/320,632.
[cited by applicant]
Final Office Action dated Jan. 17, 2024 issued in U.S. Appl. No. 17/486,165.
[cited by applicant]
Notice of Allowance dated Jan. 10, 2019 issued in copending U.S. Appl. No. 15/816,233.
[cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/415,825, dated Jul. 20, 2020.
[cited by applicant]
Office Action dated Sep. 21, 2018 issued in copending U.S. Appl. No. 15/816,233.
[cited by applicant]
Agosta F, et al.: White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology. Mar. 2011;258(3):853-63. Epub Dec. 21, 2010.
[cited by applicant]
Amazon-listed product: Mindplace Kasina DeepVision Bundle—Light and Sound Meditation Aid; https://a.co/ d/6nu7NcP; Date First Available: Nov. 6, 2015, retreived Jul. 23, 2023, 10 pages.
[cited by applicant]
Ancoli-Israel et al.: Cognitive Effects of Treating Obstructive Sleep Apnea in Alzheimer's Disease: A Randomized Controlled Study. J Am Geriatr Soc. 56(11): 2076-2081 (2008). doi: 10.1111/j.1532-5415.2008.01934.x.
[cited by applicant]
Callaghan, et al.: Long-term cognitive dysfunction in the rat following docetaxel treatment is ameliorated by the phosphodiesterase-4 inhibitor, rolipram. Behavioural brain research 290 (2015): 84-89, 6 pages.
[cited by applicant]
Deschenes, Cynthia L. et al.: Current Treatments for Sleep Disturbances in Individuals With Dementia. Curr Psychiatry Rep. 11(1):20-26 (2009).
[cited by applicant]
Doody, Rachelle S. et al.: A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease. The New England Journal of Medicine 369(4):341-350 (2013).
[cited by applicant]
Doody, Rachelle S. et al.: Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease. The New England Journal of Medicine 370(4):311-321 (2014).
[cited by applicant]
Elbeltagy, et al.: Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil. Behavioural brain research 208.1 (2010): 112-117.
[cited by applicant]
EP2018086675.1 Office Action dated Oct. 4, 2023.
[cited by applicant]
EP23150106.5 Extended European Search Report dated Jul. 5, 2023.
[cited by applicant]
Fardell, et al.: Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychopharmacology 220 (2012): 183-193, 12 pages.
[cited by applicant]
Koenig SH: Cholesterol of myelin is the determinant of gray-white contrast in MRI of brain. Magn Reson Med. Aug. 1991;20(2):285-91.
[cited by applicant]
Lim, et al.: PET evidence of the effect of donepezil on cognitive performance in an animal model of chemobrain. BioMed research international 2016 (2016), 8 pages.
[cited by applicant]
Loy, C. et al.: Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev. 2006(1):CD001747, 1-85 (2006).
[cited by applicant]
Lyons, et al.: Fluoxetine counteracts the cognitive and cellular effects of 5-fluorouracil in the rat hippocampus by a mechanism of prevention rather than recovery. PloS one 7.1 (2012): e30010, 8 pages.
[cited by applicant]
McFadden; Kristina L et al.: Test-Retest Reliability of the 40 Hz EEG Auditory Steady-State Response. PLOS One, Published: Jan. 22, 2014. https://doi.org/10.1371/journal.pone.0085748.
[cited by applicant]
Most et al.: Discrepancy Between Subjective and Objective Sleep Disturbances in Early- and Moderate-Stage Alzheimer Disease. The American Journal of Geriatric Psychiatry 20(6): 460-467 (2012). https://doi.org/10.1097/JG…
[cited by applicant]
Non-Final Office action for U.S. Appl. No. 18/160,674, dated Jun. 8, 2023.
[cited by applicant]
Notice of Allowance dated Apr. 25, 2018 for U.S. Appl. No. 15/647,157, 5 pages.
[cited by applicant]
Notice of Allowance dated Feb. 19, 2021 issued in counterpart U.S. Appl. No. 16/404,302.
[cited by applicant]
Notice of Allowance issued in U.S. Appl. No. 16/135,938 dated Sep. 21, 2021.
[cited by applicant]
Notice of Allowance issued in U.S. Appl. No. 16/156,833 dated Feb. 3, 2021.
[cited by applicant]
Notice of Allowance issued in U.S. Appl. No. 16/404,302 dated May 19, 2021.
[cited by applicant]